04 Sep Frequently Asked Questions (FAQ) – Oral Phenylephrine-Containing Products
Posted at 10:56h
in
This document consolidates SAHPRA’s responses to questions received from industry stakeholders following its 30 July 2026 communication regarding the lack of effectiveness of oral phenylephrine as a nasal decongestant.
Download latest version
Document Number:
CEM-POST08-2026/27
Version:
1
Date Updated:
04/09/2026
File Type:
www
Category:
Communication to industry